Company: ACBM
Filing Date: 2025-07-11
Form Type: 10-Q
Source: 0001640334-25-001169
Chunk: 5

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-11
Form: 10-Q
Item: Item 8
Chunk 5
---
as of September 30, 2023 and December 31, 2022, respectively. The deferred stock compensation was fully amortized at September 30, 2023.

NOTE 7 - CONCENTRATION Revenue During the three and nine months ended September 30, 2023, the Company did not generate revenue. During the three months ended September 30, 2022, the Company did not generate revenue. During the nine months ended September 30, 2022, all revenue was derived from one customer which was generated during the first quarter of 2022. Purchases During the three and nine months ended September 30, 2023, the Company did not purchase inventory. During the three months ended September 30, 2022, the Company did not purchase inventory. During the nine months ended September 30, 2022, all purchases were made from one supplier which was during the first and second quarter of 2022. Accounts receivable As of September 30, 2023 and December 31, 2022, the Company has accounts receivable consisting of customer A 0% and 56% and customer B 0% and 44%, respectively.  During the three and nine months ended September 30, 2023, the Company wrote off accounts receivable of $480,000 and did not have accounts receivable as of September 30, 2023. 

NOTE 8 - SUBSEQUENT EVENTS The Company has evaluated subsequent events that have occurred after the date of the balance sheet through the date of the issuance of these unaudited financial statements and determined that no subsequent event requires recognition or disclosure to the unaudited financial statements.

 11Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this report. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. See “Forward-Looking Statements.”

Overview

Since January 30, 2017, following a change of control, we have been engaged in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Our business has involved the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers, two of which accounted for all of our sales in the